MX2024007092A - Composiciones farmaceuticas oftalmicas y usos de las mismas. - Google Patents
Composiciones farmaceuticas oftalmicas y usos de las mismas.Info
- Publication number
- MX2024007092A MX2024007092A MX2024007092A MX2024007092A MX2024007092A MX 2024007092 A MX2024007092 A MX 2024007092A MX 2024007092 A MX2024007092 A MX 2024007092A MX 2024007092 A MX2024007092 A MX 2024007092A MX 2024007092 A MX2024007092 A MX 2024007092A
- Authority
- MX
- Mexico
- Prior art keywords
- pharmaceutical compositions
- subject
- need
- dry eye
- ophthalmic pharmaceutical
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 4
- 206010013774 Dry eye Diseases 0.000 abstract 4
- HNSGVPAAXJJOPQ-XOKHGSTOSA-N (1r,2s,5r)-n-(4-methoxyphenyl)-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)[C@H]1[C@H](C(C)C)CC[C@@H](C)C1 HNSGVPAAXJJOPQ-XOKHGSTOSA-N 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163290781P | 2021-12-17 | 2021-12-17 | |
| PCT/US2022/081775 WO2023114986A1 (en) | 2021-12-17 | 2022-12-16 | Ophthalmic pharmaceutical compositions and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024007092A true MX2024007092A (es) | 2024-06-26 |
Family
ID=85157426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024007092A MX2024007092A (es) | 2021-12-17 | 2022-12-16 | Composiciones farmaceuticas oftalmicas y usos de las mismas. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US11850221B2 (enExample) |
| EP (1) | EP4447935A1 (enExample) |
| JP (1) | JP2024544393A (enExample) |
| KR (1) | KR20240121320A (enExample) |
| CN (1) | CN118076340A (enExample) |
| AU (2) | AU2022409839B2 (enExample) |
| CA (1) | CA3242833A1 (enExample) |
| IL (1) | IL313616A (enExample) |
| MX (1) | MX2024007092A (enExample) |
| WO (1) | WO2023114986A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3242833A1 (en) | 2021-12-17 | 2023-06-22 | Alcon Inc. | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND THEIR USES |
| US20250384550A1 (en) * | 2023-06-09 | 2025-12-18 | Chung Shan Medical University | Reagent and kit for identifying and diagnosis ocular surface disease (osd) and use thereof |
| US20260027050A1 (en) * | 2024-07-23 | 2026-01-29 | Alcon Inc. | Acoltremon combinations and uses thereof |
| WO2026154426A1 (en) * | 2025-01-16 | 2026-07-23 | Alcon Inc. | Ophthalmic pharmaceutical compositions and uses thereof |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1067684A (ja) | 1996-06-17 | 1998-03-10 | Mitsubishi Chem Corp | 涙液分泌促進剤 |
| JPH10236972A (ja) | 1997-02-28 | 1998-09-08 | Mitsubishi Chem Corp | 涙液分泌促進剤 |
| JP3142842B1 (ja) | 1999-10-22 | 2001-03-07 | ライオン株式会社 | 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法 |
| US6569903B2 (en) | 1999-12-07 | 2003-05-27 | Rohto Pharmaceutical Co., Ltd. | Ophthalmic compositions |
| US20020009507A1 (en) | 2000-01-19 | 2002-01-24 | Alcon Universal Ltd. | Use of polyethoxylated castor oil for the treatment of dry eye |
| AU2003210663A1 (en) | 2002-01-25 | 2003-09-02 | The Regents Of The University Of California | Methods of modulating cold sensory perception |
| US20060084684A1 (en) | 2002-05-28 | 2006-04-20 | Altana Pharma Ag | Topically applicable pharmaceutical preparation |
| US6919348B2 (en) | 2002-05-02 | 2005-07-19 | Edward T. Wei | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| DE10259619A1 (de) | 2002-12-18 | 2004-07-08 | Metagen Pharmaceuticals Gmbh | Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung |
| CA2530884C (en) | 2003-07-02 | 2016-01-12 | Genentech, Inc. | Trp-p8 active compounds and therapeutic treatment methods |
| US20050137166A1 (en) | 2003-12-19 | 2005-06-23 | Alcon, Inc. | Use of cooling agents to relieve mild ocular irritation and enhance comfort |
| EP1802600A1 (en) | 2004-10-13 | 2007-07-04 | Bayer HealthCare AG | Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonits for the treatment of urological disorders |
| US20060111388A1 (en) | 2004-11-19 | 2006-05-25 | University Of North Texas Health Science Center At Fort Worth | Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye |
| JP5078254B2 (ja) | 2004-12-17 | 2012-11-21 | ロート製薬株式会社 | 眼科用組成物 |
| GB0504194D0 (en) | 2005-03-02 | 2005-04-06 | Givaudan Sa | Organic compounds |
| WO2007017092A1 (en) | 2005-08-04 | 2007-02-15 | Bayer Healthcare Ag | Substituted 4-benzyloxy-benzoic acid amide derivatives |
| US7727516B2 (en) | 2006-02-28 | 2010-06-01 | The Procter & Gamble Company | Reduction of hair growth |
| CN101405009B (zh) | 2006-03-23 | 2011-04-13 | 千寿制药株式会社 | 包含黄原胶和葡萄糖的眼科组合物 |
| US7887859B2 (en) | 2006-11-02 | 2011-02-15 | Riolan Technologies, Inc. | Methods of treating epiphora |
| GB2451503B (en) | 2007-08-01 | 2011-10-12 | Lrc Products | Stimulating gel comprising a cyclic carboxamide coolant |
| FR2934778B1 (fr) | 2008-08-11 | 2012-09-28 | Natura Cosmeticos Sa | Compositions d'anti-transpirants et procedes permettant de reduire la transpiration chez les humains |
| US8653099B2 (en) | 2008-08-19 | 2014-02-18 | Janssen Pharmaceutica | Cold menthol receptor antagonists |
| ES2377785B2 (es) * | 2010-09-08 | 2012-09-26 | Universidad Miguel Hernández De Elche | Composición farmacéutica para el tratamiento del ojo seco. |
| KR102073258B1 (ko) | 2014-04-15 | 2020-02-04 | 비쭈리 헬스 사이언스 엘엘씨 | 통증 완화용 국소 조성물, 제조방법 및 용도 |
| ES2625393A1 (es) | 2016-01-19 | 2017-07-19 | Universidad Miguel Hernandez De Elche | Compuestos agonistas del receptor trpm8 y sus aplicaciones |
| US20180252700A1 (en) | 2016-10-06 | 2018-09-06 | Ora, Inc. | Screening agents in dry eye disease |
| US20220080048A1 (en) * | 2016-10-12 | 2022-03-17 | PS Therapy Ltd | Opthalmological compositions and methods of use thereof |
| CN110996904A (zh) | 2017-05-19 | 2020-04-10 | 奥古根有限公司 | 眼用组合物及使用方法 |
| EP3705114A1 (en) | 2019-03-06 | 2020-09-09 | Avizorex Pharma, S.L. | Ophthalmic composition for treating dry eye and symptoms thereof |
| WO2021195256A1 (en) | 2020-03-24 | 2021-09-30 | Aerie Pharmaceuticals, Inc. | Pharmaceutical preparation |
| CA3242833A1 (en) | 2021-12-17 | 2023-06-22 | Alcon Inc. | OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND THEIR USES |
-
2022
- 2022-12-16 CA CA3242833A patent/CA3242833A1/en active Pending
- 2022-12-16 MX MX2024007092A patent/MX2024007092A/es unknown
- 2022-12-16 KR KR1020247023896A patent/KR20240121320A/ko active Pending
- 2022-12-16 AU AU2022409839A patent/AU2022409839B2/en active Active
- 2022-12-16 WO PCT/US2022/081775 patent/WO2023114986A1/en not_active Ceased
- 2022-12-16 EP EP22851338.8A patent/EP4447935A1/en active Pending
- 2022-12-16 CN CN202280067796.5A patent/CN118076340A/zh active Pending
- 2022-12-16 IL IL313616A patent/IL313616A/en unknown
- 2022-12-16 JP JP2024535940A patent/JP2024544393A/ja active Pending
- 2022-12-16 US US18/082,844 patent/US11850221B2/en active Active
-
2023
- 2023-11-15 US US18/510,437 patent/US12336971B2/en active Active
-
2025
- 2025-05-21 US US19/215,072 patent/US20250281434A1/en active Pending
-
2026
- 2026-03-11 AU AU2026201834A patent/AU2026201834A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2024544393A (ja) | 2024-11-29 |
| EP4447935A1 (en) | 2024-10-23 |
| IL313616A (en) | 2024-08-01 |
| AU2022409839B2 (en) | 2025-12-11 |
| US12336971B2 (en) | 2025-06-24 |
| CN118076340A (zh) | 2024-05-24 |
| US20230233493A1 (en) | 2023-07-27 |
| WO2023114986A1 (en) | 2023-06-22 |
| AU2026201834A1 (en) | 2026-04-02 |
| CA3242833A1 (en) | 2023-06-22 |
| US20250281434A1 (en) | 2025-09-11 |
| US20240091179A1 (en) | 2024-03-21 |
| KR20240121320A (ko) | 2024-08-08 |
| AU2022409839A1 (en) | 2024-07-11 |
| US11850221B2 (en) | 2023-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA39767B1 (fr) | Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'œil sec | |
| EP4684836A3 (en) | Combinations of lsd1 inhibitors for use in the treatment of neoplastic diseases | |
| MY166228A (en) | Compositions comprising mixtures of semifluorinated alkanes | |
| MX2024001713A (es) | Metodos y composiciones para tratar la apnea del sue?o. | |
| CL2020003225A1 (es) | Una composición de pienso para la prevención o el tratamiento de la enfermedad de la necrosis hepatopancreática aguda (ahpnd, por su sigla en inglés) o el síndrome de las manchas blancas (wss, por su sigla en inglés), que comprende una cepa de bacillus subtilis como un componente activo. (divisional de solicitud n° 01463-2019) | |
| WO2016029027A3 (en) | Methods and compositions for the prevention and treatment of disease | |
| CL2023000699A1 (es) | Tratamientos de angioedema | |
| MX2019001577A (es) | Composiciones farmaceuticas y usos dirigidos a los trastornos del almacenamiento lisosomal. | |
| CO2022006066A2 (es) | Agente terapéutico y agente profiláctico para trastornos gastrointestinales funcionales y xerostomía | |
| EP4591928A3 (en) | Composition for the treatment of gastroesophageal reflux comprising hyaluronic acid | |
| ZA202004849B (en) | Therapeutic agents for treating restless legs syndrome | |
| EP4234022A3 (en) | Betahistine, or a pharmaceutically acceptable salt thereof, and a monoamine oxidase inhibitor, for use in the treatment or prevention of one or more symptoms of vertigo in a subject | |
| MX2017009325A (es) | Gel intestinal de levodopa y carbidopa y metodos de uso. | |
| EP4218744A4 (en) | PROPHYLACTIC, RELIEF AND THERAPEUTIC AGENT FOR DRY EYE | |
| WO2020109233A3 (en) | Trmt2a inhibitors for use in the treatment of polyglutamine diseases | |
| AR098832A1 (es) | Uso de laquinimod para retrasar la progresión de la enfermedad de huntington | |
| WO2023285686A3 (en) | Recombinant variants of r-spondin proteins and their use | |
| WO2020023094A3 (en) | Treatment of lysosomal storage disorders | |
| MX2023005829A (es) | Combinaciones farmaceuticas para tratar el cancer. | |
| WO2020159159A3 (ko) | 리소좀 축적 질환의 예방 또는 치료를 위한 약학적 조성물 | |
| WO2022025785A8 (ru) | Фармацевтическая композиция, включающая мемантин и цитиколин | |
| MX2018004779A (es) | Uso terapeutico de una solucion oftalmica acuosa esteril. | |
| WO2019190427A3 (en) | The immediate release combination comprising raloxifene and at least one antipsychotic agent | |
| CL2021002853A1 (es) | Composición para la prevención o el tratamiento de la caída del cabello que incluye hapln1 | |
| MX2018005453A (es) | Uso terapeutico de una solucion oftalmica acuosa esteril. |